EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

How improvements to drug effectiveness impact mass drug administration for control and elimination of schistosomiasis

John R Ellis iD, Nyamai Mutono, Andreia Vasconcelos, Samuel M Thumbi, T Déirdre Hollingsworth, Roy M Anderson

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0012624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von John R Ellis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease Epidemiology, School of Public Health, Faculty of Medicine, White City Campus, Imperial College London, London, Unit…. Hauptthemen laut MEDLINE: Mass Drug Administration, Schistosomiasis, Praziquantel, Anthelmintics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schistosomiasis affects more than 230 million people worldwide. Control and elimination of this parasitic infection is based on mass drug administration of praziquantel (PZQ), which has been in use for several decades. Because of the limitations of the efficacy of PZQ especially against juvenile worms, and the threat of the emergence of resistance, there is a need to consider alternative formulations or delivery methods, or new drugs that could be more efficacious. We use an individual-based stochastic model of parasite transmission to investigate the effects of possible improvements to drug efficacy. We consider an increase in efficacy compared to PZQ, as well as additional efficacy against the juvenile life stage of schistosome parasites in the human host, and a slow-release formulation that would provide long-lasting efficacy for a period of time following treatment. Analyses suggest a drug with a high efficacy of 99%, or with efficacy lasting 24 weeks after treatment, are the two most effective individual improvements to the drug profile of PZQ. A drug with long lasting efficacy is most beneficial when MDA coverage is low. However, when prevalence of infection has already been reduced to a low level, a high efficacy is the most important factor to accelerate interruption of transmission. Our results indicate that increased efficacy against juvenile worms can only result in modest benefits, but the development of a new drug formulation with higher efficacy against adult worms or long-lasting efficacy would create an improvement to the community impact over the currently used formulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mass Drug AdministrationSchistosomiasisPraziquantelAnthelminticsHumansAnimalsTreatment OutcomeSchistosomaDisease Eradication

Substanzen

PraziquantelAnthelmintics

Autor:innen und Institutionen

  • Department of Infectious Disease Epidemiology, School of Public Health, Faculty of Medicine, White City Campus, Imperial College London, London, United Kingdom.
  • Centre for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya.
  • Paul G. Allen School for Global Health, Washington State University, Pullman, Washington, United States of America.
  • Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom.
  • Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford, United Kingdom.
  • Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.

ORCID-Profile: John R Ellis

Förderung

  • Gates Foundation
  • Bill and Melinda Gates Foundation

Zitieren

APA

Ellis, J. R., Mutono, N., Vasconcelos, A., Thumbi, S. M., Hollingsworth, T. D., & Anderson, R. M. (2025). How improvements to drug effectiveness impact mass drug administration for control and elimination of schistosomiasis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012624

Vancouver

Ellis JR, Mutono N, Vasconcelos A, Thumbi SM, Hollingsworth TD, Anderson RM. How improvements to drug effectiveness impact mass drug administration for control and elimination of schistosomiasis. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012624

BibTeX
@article{Ellis2025,
  author = {Ellis, John R and Mutono, Nyamai and Vasconcelos, Andreia and Thumbi, Samuel M and Hollingsworth, T Déirdre and Anderson, Roy M},
  title = {How improvements to drug effectiveness impact mass drug administration for control and elimination of schistosomiasis},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0012624}
}
Kostenlos starten →